Gain Therapeutics' Parkinson's Drug Shows Promise: Key Biomarker Data Coming Mid-2025 - Stock Titan
4 weeks ago • Google News
Gain Therapeutics Inc (GANX)
US$ 2.215-0.67%
Price Chart
Key Statistics
Market Cap
$ 57.5M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
156.01K
52W High
$ 3.19
52W Low
$ 0.89
Dividend Yield
0.00%
Beta
0.11
Technicals
50-Day MA
1.8634
200-Day MA
1.9465
52 Week High
3.19
52 Week Low
0.89
About GANX
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.
Employees
23
Headquarters
Bethesda, MD
CEO
Dr. Khalid Islam Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg